Harini Gopalakrishnan
Harini Gopalakrishnan
GTM & Strategy - Health & Lifesciences

Why Life Sciences AI Is a Search Problem (Part 5 of 5)

Why Life Sciences AI Is a Search Problem (Part 5 of 5)

Photo by Louis Reed on Unsplash

The future of GenAI in pharma and healthcare isn’t about building bigger models — it’s about smarter retrieval.


Originally presented at the Fierce Pharma Webinar: “You Have the Model, Now What? Lessons on Making AI Work in Life Sciences and Breaking the Chatbot Mirage.” This is a five part quick read series that summarizes the panel discussion highlighting key topics of the conversations.

This recap of the Fierce Pharma x Vespa.ai panel distills how leaders from Novo Nordisk, Alkermes, and Harvard Medical School are reframing AI as a search and retrieval problem, powered by context, tensors, and explainability.

→ Full video: fierce-pharma-webinar


The take away: Why It’s a Search Problem

Search is the new foundation for intelligence.

Throughout the discussion, one idea kept resurfacing:

“You can’t trust a model to know everything. You must retrieve the right context — every time.”

At the end of the day, the healthcare & lifesciences value chain is all about search:

  • Drug discovery → searches molecular space.
  • Clinical teams → search patient cohorts across multi modal data
  • Commercial teams → search for relevant brand content
  • Payers search → member journeys.

Even AI itself searches its own embeddings.

That’s why the future of health & life sciences AI is not about building ever-larger LLMs, but creating smarter retrieval systems — where context is the currency. Vespa.ai is the engine powering it.

Design for retrieval first — and intelligence will follow.


Read more